Letter comments on: “Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan”

International Journal of Hematology 2026

View at publisher

Authors: Rajesh Prasad Jayaswal, Rama Kumari Badyal, Rahul Kumar Ranawat

DOI: 10.1007/s12185-026-04226-x

Cited by: 1

References: 3

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Acute Lymphoblastic Leukemia research

References 3